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Table S1. Schedule of the present study.  
 
 
Days after virus inoculation  
 
0 1 2 3 4 5 6 7 
Swab sampling ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 
Blood sampling ✓ ✓  ✓  ✓  ✓ 
Antivirals/saline 
administration 
 ✓ ✓ ✓ ✓ ✓   
 
Cynomolgus macaques were challenged with H5N6 HPAIV on day 0. Swab and/or blood 
samplings were done before virus infection and before antiviral drugs/saline administration on 




Table S2. Virus titers in tissue samples from cynomolgus macaques on day 7 after A/black swan/Akita/1/2016 (H5N6) virus infection  
Tissue  
Virus titer (log10TCID50/g) on day 7 post infection  
Saline Oseltamivir Peramivir Amantadine 
S1a S2 S3 O1 O2 O3 P1 P2 P3 A1 A2 A3 
Nasal mucosa 2.50 2.67 < b < < < < < < < 3.50 < 
Oronasopharynx 3.50 4.00 ≤ 2.00 e < < < ≤ 1.67 c 2.50 < < ≤ 1.83 d < 
Right tonsil 2.67 3.67 4.00 < < < 4.50 4.67 < < < < 
Left tonsil 4.56 3.77 3.83 < < < ≤ 2.00 4.77 ≤ 2.00 < ≤ 1.67 < 
Trachea < 2.67 ≤ 2.00 < ≤ 1.67 < < < < < ≤ 1.67 < 
Right bronchus  ≤ 1.67 2.67 ≤ 2.50 h < < < < < < < < 3.00 
Left bronchus  2.67 2.67 < < < < < < < < < ≤ 1.83 
Right upper lung < < < < < < ≤ 3.17 j < < < < < 
Right middle lung ≤ 1.67 ≤ 2.33 g < < < < < < 4.50 < < ≤ 3.00 i 
Right lower lung < ≤ 2.33 < < < < ≤ 2.33 ≤ 1.83 < < < < 
Left upper lung < ≤ 2.33 < < < < < 2.00 ≤ 1.67 < < ≤ 1.67 
Left middle lung < < < < < < 3.67 ≤ 2.23 f < < < ≤ 1.83 
Left lower lung 2.50 < < < < < ≤ 2.50 4.00 < < < < 
 
a: Macaque identification.  
b<: No cytopathic effect (CPE)-positive well in quadruplicate culture. A detection limit is 1.67 log10TCID50/g tissue. 
c≤ 1.67: One CPE-positive well in quadruplicate culture with undiluted samples was observed. 
d≤ 1.83: Two CPE-positive wells were observed in quadruplicate culture: one with undiluted samples and one with 10-fold diluted samples. 
e≤ 2.00: Two CPE-positive wells in quadruplicate culture with undiluted samples were observed. 
f≤ 2.23: Two and one CPE-positive wells were observed in quadruplicate culture of undiluted and 10-fold diluted samples, respectively. 
g≤ 2.33: Three CPE-positive wells in quadruplicate culture with undiluted samples were observed. 
h≤ 2.50: Four CPE-positive wells were observed in quadruplicate culture: two with undiluted samples and two with 10-fold diluted samples. 
i ≤ 3.00: Two and three CPE-positive wells were observed in quadruplicate culture of undiluted and 10-fold diluted samples, respectively. 
j≤ 3.17: Six CPE-positive wells were observed in quadruplicate culture: three with undiluted samples and three with 10-fold diluted samples.
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Table S3. Clinical scoring 
Parameter Degree of parameter Possible score 
Fever Normal (< 39 oC) 0 
 Elevated temperature (39-40 oC) 3 
 High temperature (> 40 oC) 5 
Posture Piloerection of body hair 1 
 Decreased activity, decreasing normal 
behavior/Occasionally lying down, huddled, active 
when people in room 
2 
 Huddled on camera, active when people in 
room/Lying down, getting up when approached, 
using cage for support 
3 
 Huddled when people in room, shaking, toes and 
hands clenched/Lying down, not getting up when 
approached or prompted 
5 
Respiration Increased or decreased; mild cough and clear nasal 
discharge 
3 
 Labored breathing through mouth; severe cough and 
severe nasal discharge 
5 
Appetite Slightly decreased 1 
 Decreased 2 
 Severely decreased 5 
Skin Flushed appearance 2 
 Visible rash 2 








Fig S1. Virus titer AUCs in swab samples collected from cynomolgus macaques challenged 
with A/black swan/Akita/1/2016 (H5N6). The virus titer areas under the concentration-time 
curves (AUC, the summation of virus titers) of individual macaques were calculated on the basis 
of results in Table 1. The detection limit of virus titers in swab samples was 0.67 log10TCID50/mL. 
Virus titer AUCs of the virus titers (log10TCID50/mL) from days 1 to day 7 and from day 2 to day 
7 were calculated by use of the trapezoidal rule. Thereafter, averages and standard deviations of 
the virus titer AUC of three macaques in each group were calculated. Left bars: AUC from day 1 
to day 7 (including before treatment). Right bars: AUC from day 2 to day 7 (after treatment). The 
result of no CPE positive detection was counted as 0. When the result is lower than a certain number 
(for example, ≤ 0.67), we took that number (0.67) as the value of the virus titer, then analyzed data 




Fig S2. Pneumonia of cynomolgus macaques challenged with A/black swan/Akita/1/2016 (H5N6). (a) 
H&E sections of right lower lung lobes of 12 cynomolgus macaques and an uninfected macaque are shown. 
Images on the right column: immunohistochemical staining for CD163 (representative images of one 
macaque in each group). Bars, 50 µm. (b) Averages of acute lung injury (ALI) scores. ALI scores were 
assessed by two pathologists who were blind to the macaque identification number. There is no significant 
difference in ALI scores among four groups. (c) The number of BALTs was counted on H&E staining 
sections of each lung lobe of macaques. The average BALT number/lobe was used to compare among the 





Fig S3. Levels of plasma and lung tissue cytokines in cynomolgus macaques challenged with 
A/black swan/Akita/1/2016 (H5N6). (a-c) The averages and standard deviations of cytokine 
concentrations in plasma after virus infection measured by a bead array assay. (a) IFN-γ, (b) TNF-
α, (c) IL-4. (d-f) The concentrations of cytokines/chemokines in the lung tissues on day 7. The lung 






Fig S4. Correlation between IFN-α and virus titers in cynomolgus macaques after H5N6 virus 
infection. (a, b) Correlations of IFN-α concentration on day 1 with virus titers in the trachea (a) 









Fig. S5. Efficacy of antiviral drugs against A/Aichi/2/1968 (H3N2) virus in vitro. 
MDCK cells were infected with the virus at a multiplicity of infection (MOI) of 0.01 and cultured 
with antiviral drugs of various concentrations: (a) oseltamivir, (b) peramivir, and (c) amantadine. 
The supernatant of each well was collected at 24 h after virus infection. Then virus titers in the 
supernatants were determined by the Reed Muench method. Averages and standard deviations of 
three independent experiments were shown. The asterisk shows a significant difference in virus 
titers between with and without antiviral drugs (Student’s t-test, *: P < 0.05).  
 
